Titlebook: Ethical Challenges in Cancer Diagnosis and Therapy; Axel W. Bauer,Ralf-Dieter Hofheinz,Jochen S. Utika Book 2021 Springer Nature Switzerla

SORB

書目名稱Ethical Challenges in Cancer Diagnosis and Therapy影響因子(影響力)




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy影響因子(影響力)學(xué)科排名




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy網(wǎng)絡(luò)公開度




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy被引頻次




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy被引頻次學(xué)科排名




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy年度引用




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy年度引用學(xué)科排名




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy讀者反饋




書目名稱Ethical Challenges in Cancer Diagnosis and Therapy讀者反饋學(xué)科排名

省略

cardiovascular

HPV Vaccination in Bangladesh: Ethical Views,countries. Bangladesh, a lower-middle income country, observed a successful HPV vaccination demonstration program recently. As much as the benefits of the vaccination programs are well-recorded, the ethics of administration of it is not focused highly; rather the focus tends to be on the most effici

padding

Pde5-Inhibitors

Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case ofo risk-reduction measures for persons at high and moderate genetic cancer risk (Meier et al. Risikoadaptierte Pr?vention’. Governance Perspective für Leistungsansprüche bei genetischen (Brustkrebs-)Risiken, Springer, Wiesbaden, .). The German context specifics are summarized to enable the source tex

羞辱

The Right to Know and not to Know: Predictive Genetic Diagnosis and Non-diagnosis,e and responsible—sometimes radical—prevention. In the area of mamma carcinoma, the ‘Angelina Jolie effect’ has not only been a media topic but has had real consequences. The undisputed right to knowledge is increasingly taking on the character of a general recommendation or even norm for society as

羞辱

Harms and Benefits of Cancer Screening,ing the case for cancer screening, building a service programme, monitoring its operation, improving its quality and integrating it with medical progress. The value of (first) screening is derived as a function of key parameters: prevalence of the target lesion in the detectable pre-clinical phase,

ferment

Myocyte

Ethical Aspects of Regulating Oncology Products,e medicines, evolved to cover all aspects of research around the quality, safety and efficacy of candidate medicines. This chapter intends to give an introduction on what regulators do and where the ethical foundations for regulating medicines might be searched. Some specific dilemmas will be explor

sclera